Gilead and Teva are not liable for antitrust violations which insurers and other drug purchasers said was a "pay-to-delay" scheme designed to illegally maximize the manufacturers' profits.
A jury reached a defense verdict on Tuesday in a patent lawsuit filed by the U.S. government over Gilead's HIV drugs.
Gilead has filed a lawsuit against the U.S. government, claiming it breached multiple contractual agreements by pursuing patents on Truvada during the company's collaboration with the CDC.
A new analysis shows Gilead is rapidly convincing Truvada users to switch over to Descovy before the drug goes generic, amid claims it kept the safer drug shelved for years…
A Justice Department lawsuit accuses Gilead of patent infringement in its sale of Truvada and Descovy as HIV prevention drugs.
A patent lawsuit has been filed by the makers of Abilify, who say another company is violating its patent by planning to release multiple generic versions of the drug.
